Traphagen Investment Advisors LLC lifted its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 2.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 4,969 shares of the company’s stock after purchasing an additional 105 shares during the quarter. Traphagen Investment Advisors LLC’s holdings in Procter & Gamble were worth $833,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also added to or reduced their stakes in PG. Fiera Capital Corp grew its holdings in shares of Procter & Gamble by 1,135.1% during the 2nd quarter. Fiera Capital Corp now owns 20,688 shares of the company’s stock worth $3,412,000 after purchasing an additional 19,013 shares in the last quarter. Wescott Financial Advisory Group LLC grew its holdings in shares of Procter & Gamble by 10.1% during the 2nd quarter. Wescott Financial Advisory Group LLC now owns 23,146 shares of the company’s stock worth $3,817,000 after purchasing an additional 2,114 shares in the last quarter. Fred Alger Management LLC grew its holdings in shares of Procter & Gamble by 4.7% during the 2nd quarter. Fred Alger Management LLC now owns 67,580 shares of the company’s stock worth $11,145,000 after purchasing an additional 3,006 shares in the last quarter. Trinity Legacy Partners LLC grew its holdings in shares of Procter & Gamble by 1.2% during the 2nd quarter. Trinity Legacy Partners LLC now owns 33,219 shares of the company’s stock worth $5,478,000 after purchasing an additional 409 shares in the last quarter. Finally, Prairie Wealth Advisors Inc. grew its holdings in shares of Procter & Gamble by 3.0% during the 2nd quarter. Prairie Wealth Advisors Inc. now owns 3,453 shares of the company’s stock worth $569,000 after purchasing an additional 99 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble Trading Up 1.8 %
Shares of PG stock opened at $164.57 on Thursday. The stock has a market cap of $387.56 billion, a price-to-earnings ratio of 28.37, a PEG ratio of 3.63 and a beta of 0.45. The stock has a 50-day moving average of $169.01 and a 200-day moving average of $169.41. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 1-year low of $152.06 and a 1-year high of $180.43.
Procter & Gamble Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be paid a dividend of $1.0065 per share. The ex-dividend date is Friday, January 24th. This represents a $4.03 annualized dividend and a yield of 2.45%. Procter & Gamble’s dividend payout ratio is currently 69.48%.
Insider Buying and Selling
In related news, CEO Gary A. Coombe sold 47,847 shares of the firm’s stock in a transaction that occurred on Wednesday, November 27th. The stock was sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the completion of the sale, the chief executive officer now owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of the firm’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the sale, the insider now directly owns 11,595 shares of the company’s stock, valued at $2,002,804.35. This represents a 52.47 % decrease in their position. The disclosure for this sale can be found here. 0.18% of the stock is currently owned by insiders.
Analysts Set New Price Targets
Several analysts have recently issued reports on the company. UBS Group reduced their target price on Procter & Gamble from $196.00 to $189.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. Morgan Stanley upped their price objective on Procter & Gamble from $174.00 to $191.00 and gave the stock an “overweight” rating in a research report on Monday, October 21st. Evercore ISI upped their price objective on Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. Wells Fargo & Company dropped their price objective on Procter & Gamble from $190.00 to $176.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Finally, Barclays dropped their price objective on Procter & Gamble from $163.00 to $155.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Eight investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $179.65.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- What is the Australian Securities Exchange (ASX)
- Oracle Announces Game-Changing News for the AI Industry
- What is the Nikkei 225 index?
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.